7, 2025: nerandomilast Boehringer Ingelheims oral phosphodiesterase 4B (PDE4B) inhibitor nerandomilast is undergoing a Priority Review for the treatment of idiopathic pulmonary fibrosis (IPF)
This article reviews results from the SOUL (Semaglutide Cardiovascular Outcomes) trial, whose aim was to assess the cardiovascular benefit in oral semaglutide in high-risk individuals
Distinguishing Between Telogen Effluvium, Androgenetic Alopecia, and Alopecia Areata If youre experiencing hair loss, its important to establish what kind of hair loss you might be having before any treatment can be recommended
Discussing these concerns with your prescribing provider or a mental health professional helps restore confidence
Its less about total bans and more about being smart with timing and amount
Utrata masy ciaa to efekt jego dziaania metabolicznego, a nie efekt spalania tuszczu w sensie farmakologicznym